ArticleJournal of experimental & clinical cancer research : CR2018

SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.

Hongliang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.